2024/11/08

Advancing the frontiers of Glycoscience at Glycobasque 7

Professionals, experts, and researchers from diverse glycoscience disciplines, including glycobiology, immunology, and carbohydrate chemistry, converged at Glycobasque 7, held on November 7th and 8th.

This event provided a platform for sharing cutting-edge insights, fostering collaboration, and advancing knowledge within the dynamic and rapidly evolving field of glycoscience.

The seventh edition of the international glycoscience congress, Glycobasque 7, was held on November 7th and 8th at the auditorium of the Edificio Barco (Building 101) at the Bizkaia Technology Park in Zamudio. The event, organized by Jesús Jiménez-Barbero from CIC bioGUNE and Niels Reichardt from CIC biomaGUNE, both members of the Basque Research and Technology Alliance (BRTA), gathered professionals, experts, and researchers from various glycoscience disciplines, including glycobiology, immunology, and carbohydrate chemistry.

Glycobasque 7 served as a vibrant forum for exchanging cutting-edge knowledge, fostering collaboration, and advancing glycoscience research. Over the course of two days, the conference hosted seminars by renowned international speakers, including Matthew Macauley (University of Alberta), Vered Padler-Karavani (Tel Aviv University), Jim Paulson (Scripps Research Institute), Matthieu Sollogoub (Sorbonne University), and Manfred Wuhrer (Leiden University). These experts presented key topics in the field, such as glycoimmunology in cancer and infectious diseases, carbohydrate-lectin interaction analysis techniques, glycomimetics development, and advanced carbohydrate synthesis methodologies.

Glycoscience is becoming increasingly important in vital fields such as drug discovery, gene therapy, regenerative medicine, and disease diagnostics. This meeting underlined the enormous prospects that glycoscience provides for basic and translational research.

Participants were exposed to cutting-edge research in areas such as cancer glycobiology, glycan synthesis, immunological treatment, glycoconjugate vaccine design, and carbohydrate-protein interaction studies. The conference emphasized the relevance of glycoscience in generating enhanced public health solutions while also encouraging researchers and industry leaders to exchange ideas.

The organizers expressed their gratitude to all participants, sponsors, and collaborators who played a crucial role in the success of this significant international meeting.

About CIC bioGUNE
The Centre for Cooperative Research in Biosciences (CIC bioGUNE), a member of the Basque Research and Technology Alliance (BRTA), located in the Bizkaia Technology Park, is a biomedical research organization conducting cutting-edge research at the interface between structural, molecular, and cell biology, with a particular focus on generating knowledge on the molecular basis of diseases for use in developing new diagnostic methods and advanced therapies.

About CIC biomaGUNE
The Center for Cooperative Research in Biomaterials CIC biomaGUNE, also a member of BRTA, conducts state-of-the-art research at the interface between chemistry, biology, and physics, focusing particularly on studying the properties of biological nanostructures at the molecular scale and their biomedical applications.

About BRTA
BRTA is an alliance of 4 collaborative research centres (CIC bioGUNE, CIC nanoGUNE, CIC biomaGUNE y CIC energiGUNE) and 13 technology centres (Azterlan, Azti, Ceit, Cidetec, Gaiker, Ideko, Ikerlan, Leartiker, Lortek, Neiker, Tecnalia, Tekniker y Vicomtech) with the main objective of developing advanced technological solutions for the Basque corporate fabric.

With the support of the Basque Government, the SPRI Group and the Provincial Councils of the three territories, the alliance seeks to promote collaboration between the research centres, strengthen the conditions to generate and transfer knowledge to companies, contributing to their competitiveness and outspreading the Basque scientific-technological capacity abroad.

BRTA has a workforce of 3,500 professionals, executes 22% of the Basque Country's R&D investment, registers an annual turnover of more than 300 million euros and generates 100 European and international patents per year.

Spanish version